- Trials with a EudraCT protocol (89)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
89 result(s) found for: Atrial Natriuretic Peptide.
Displaying page 1 of 5.
EudraCT Number: 2013-000797-30 | Sponsor Protocol Number: SPI-IIT-002 | Start Date*: 2013-10-08 | |||||||||||||||||||||
Sponsor Name:Department of Medical Research, Odense University Hospital, Svendborg Hospital | |||||||||||||||||||||||
Full Title: Inhibition of aldosterone to diminish diffuse myocardial fibrosis in atrial fibrillation | |||||||||||||||||||||||
Medical condition: Paroxysmal and persistent atrial fibrillation | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-005043-13 | Sponsor Protocol Number: RG_14-187 | Start Date*: 2016-08-11 | |||||||||||
Sponsor Name:University of Birmingham | |||||||||||||
Full Title: Evaluating different rate control therapies in permanent atrial fibrillation: A prospective, randomised, open-label, blinded endpoint study comparing digoxin and beta-blockers as initial rate contr... | |||||||||||||
Medical condition: Atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002404-41 | Sponsor Protocol Number: MOSES | Start Date*: 2022-08-26 |
Sponsor Name:PD Dr. med. Mira Katan | ||
Full Title: Midregional proatrial natriuretic peptide to guide secondary stroke prevention: The MOSES-study | ||
Medical condition: Patients with ischemic stroke and elevated midregional proatrial natriuretic peptide (MRproANP) levels without known atrial fibrillation. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001131-31 | Sponsor Protocol Number: FHC-1-2012 | Start Date*: 2012-06-14 | |||||||||||
Sponsor Name:Department of Medical Research | |||||||||||||
Full Title: Effekts of nebivolol on the nitric oxide system in patients with essentiel hypertension | |||||||||||||
Medical condition: Essential Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003702-33 | Sponsor Protocol Number: RG_14-150 | Start Date*: 2015-01-23 | |||||||||||||||||||||
Sponsor Name:University of Birmingham | |||||||||||||||||||||||
Full Title: IMPRESS-AF: IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation | |||||||||||||||||||||||
Medical condition: Atrial fibrillation with preserved left ventricular systolic function and normal levels of the brain natriuretic peptide. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-003921-13 | Sponsor Protocol Number: 12/0368 | Start Date*: 2013-06-07 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: COMbination therapy for PulmonAry hypertension using RacEcadotril (COMPARE). | |||||||||||||
Medical condition: Pulmonary hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002928-53 | Sponsor Protocol Number: HBT-GCP-PTCL-01 | Start Date*: 2015-11-16 |
Sponsor Name:The Heartbeat Trust | ||
Full Title: Personalised prospective comparison of ARni with ArB in patients with natriuretic peptide eLEvation (PARABLE) | ||
Medical condition: Patients (asymptomatic) with cardiovascular risk factors for heart failure including either hypertension and/or type II diabetes, with elevated levels of natriuretic peptide (brain natriuretic pept... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005083-81 | Sponsor Protocol Number: ALBUCARD | Start Date*: 2006-06-09 |
Sponsor Name:HOSPITAL CLINIC | ||
Full Title: EFECTOS DE LA ADMINISTRACIÓN DE ALBÚMINA INTRAVENOSA SOBRE LA FUNCIÓN DIASTÓLICA DE LOS PACIENTES CON CIRROSIS HEPÁTICA. | ||
Medical condition: Liver cirrhosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001626-26 | Sponsor Protocol Number: OMT28-C0201 | Start Date*: 2019-01-23 | |||||||||||
Sponsor Name:OMEICOS Therapeutics GmbH | |||||||||||||
Full Title: A Placebo-controlled, double-blind, Randomized, dose finding phase II study on OMT-28 in MaIntenance of Sinus rhythm after Electrical cardioversion in patients with persistent Atrial Fibrillation (... | |||||||||||||
Medical condition: Persistent atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) BG (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003510-16 | Sponsor Protocol Number: EFC15156 | Start Date*: 2018-05-07 | ||||||||||||||||
Sponsor Name:Lexicon Pharmaceuticals, Inc. | ||||||||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effects of Sotagliflozin on Clinical Outcomes in Hemodynamically Stable Patients with Type 2 Diabet... | ||||||||||||||||||
Medical condition: Cardiovascular diseases | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Completed) NL (Completed) ES (Prematurely Ended) LV (Completed) LT (Completed) GB (Completed) BE (Completed) DK (Prematurely Ended) FR (Completed) AT (Completed) CZ (Prematurely Ended) DE (Completed) SK (Completed) HU (Completed) FI (Completed) PT (Completed) GR (Completed) PL (Completed) IE (Completed) IT (Completed) RO (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-001636-60 | Sponsor Protocol Number: SL-3-2019 | Start Date*: 2019-07-12 | |||||||||||
Sponsor Name:University clinic of Nephrology and Hypertension, Regional Hospital Holstebro | |||||||||||||
Full Title: The effect of spironolactone on renal hemodynamics in patients with essential hypertension | |||||||||||||
Medical condition: Physiological responses in patients with essential hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001930-34 | Sponsor Protocol Number: 170674-3479 | Start Date*: 2005-11-25 |
Sponsor Name:Department of Cardiology, Odense University Hospital | ||
Full Title: Left ventricular reverse remodelling after aortic valve replacement in severe valvular aortic stenosis - effect of blockade of the angiotensin-II receptor | ||
Medical condition: Patients with severe aortic valve stenosis treated with Aortic Valve Replacement (AVR) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002516-33 | Sponsor Protocol Number: NCT01420393 | Start Date*: 2015-09-03 |
Sponsor Name:University of Ottawa Heart Institute | ||
Full Title: A Randomized Ablation-based atrial Fibrillation rhythm control versus rate control Trial in patients with heart failure and high burden Atrial Fibrillation | ||
Medical condition: The study is comparing two accepted treatment methods (rhythm control-Catheter ablation with or without anti-arrhythmic drug control of maintaining sinus rhythm versus rate controls with medical th... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001643-21 | Sponsor Protocol Number: 2007OE002B | Start Date*: 2008-06-26 | |||||||||||
Sponsor Name:Royal Brompton and Harefield NHS Trust | |||||||||||||
Full Title: Use of endothelin-1 antagonists in patients with Established Pulmonary Hypertension and Fibrotic Lung Disease. – A randomised, placebo-controlled, double-blinded study. | |||||||||||||
Medical condition: Pulmonary hypertension in patients with interstitial lung disease. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000805-27 | Sponsor Protocol Number: MEIN/10/Ran-Did/001 | Start Date*: 2012-10-23 | |||||||||||
Sponsor Name:Menarini International Operations Luxembourg S.A., Avenue de la Gare, 1611 Luxembourg, Luxembourg | |||||||||||||
Full Title: Effect of Ranolazine in Heart Failure Patients with Preserved Ejection Fraction | |||||||||||||
Medical condition: Heart failure patients with preserved ejection fraction (HFpEF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004072-59 | Sponsor Protocol Number: 1245-0167 | Start Date*: 2018-04-03 |
Sponsor Name:Boehringer-Ingelheim España, S.A. | ||
Full Title: A phase III randomised, double-blind trial to evaluate the effect of 12 weeks treatment of once daily EMPagliflozin 10 mg compared with placebo on ExeRcise ability and heart failure symptoms, In pa... | ||
Medical condition: Chronic Heart Failure with preserved Ejection Fraction (HFpEF) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) GR (Completed) PT (Completed) PL (Completed) SE (Completed) NO (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-002732-25 | Sponsor Protocol Number: 0105 | Start Date*: 2006-02-01 |
Sponsor Name:Geir Øystein Andersen, Department of Cardiology, Ulleval University Hospital | ||
Full Title: Safety and efficacy of levosimendan in patients with acute myocardial infarction complicated by symptomatic left ventricular failure | ||
Medical condition: Patients with acute myocardial infarction developing acute heart failure after primary PCI (percutaneus coronary intervention). Some patients in a predefined subgroup are categorized as patients in... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003404-39 | Sponsor Protocol Number: JBR-2-2013 | Start Date*: 2014-01-03 | |||||||||||
Sponsor Name:Department of Medical Research, Regional Hospital Holstebro | |||||||||||||
Full Title: The effect of sodium nitrite infusion on renal variables, brachial and central blood pressure during enzyme inhibition by allopurinol, enalapril or acetazolamid in healthy subjects. A randomized, d... | |||||||||||||
Medical condition: The normal physiological responses in healthy subjects | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000298-65 | Sponsor Protocol Number: BAY1021189/19334 | Start Date*: 2018-06-11 | |||||||||||
Sponsor Name:Bayer AG | |||||||||||||
Full Title: A randomized parallel-group, placebo-controlled, double-blind, multi-center trial to eValuate the effIcacy and safeTy of the orAL sGC stImulator vericiguaT to improve phYsical functioning in activi... | |||||||||||||
Medical condition: Heart failure and preserved ejection fraction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) PT (Completed) AT (Completed) ES (Completed) HU (Completed) BG (Completed) GR (Completed) PL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001169-33 | Sponsor Protocol Number: SAFA-1-2012 | Start Date*: 2012-07-02 | ||||||||||||||||
Sponsor Name:Department of Medical Research | ||||||||||||||||||
Full Title: Effects of tolvaptan on renal sodium and water handling and circulation during inhibition of the nitric oxide system in healthy subjects | ||||||||||||||||||
Medical condition: SIADH (Syndrome of inappropriate ADH production) Overhydration Hyponatrimia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
![](img/rss.png)
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
![](img/info.png)